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[57]	 ABSTRACT
Normal mammalian tissue and the culturing process has
been developed for the three groups of organ, structural and
blood tissue. The cells are grown in vitro under microgravity
culture conditions and form three dimensional cells aggre-
gates with normal cell function. The microgravity culture
conditions may be microgravity or simulated microgravity
created in a horizontal rotating wall culture vessel.
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MEDIA COMPOSTI'IONS FOR THREE -
DIMENSIONAL MAMMALIAN TISSUE
GROWTH UNDER MICROGRAVITY
CULTURE CONDITIONS
This is a divisional of application Ser. No. 08/066.292
filed May 25, 1993. now U.S. Pat. No. 5.496,722, which is
a continuation-in-part of application Ser. No. 07/939,791,
filed Sep. 3. 1992, now U.S. Pat. No. 5-308.764. which is a
continuation of application Ser. No. 07/317,391, filed Mar.
2, 1989, now U.S. Pat. No. 5.153.132, which is a
continuation-in-part of application Ser. No. 07/317,776.
filed Mar. 2, 1989, now U.S. Pat. No. 5,155.034, which is a
continuation-in-part of application Ser. No. 07/213.588.
filed Jun. 30. 1988, now U.S. Pat. No. 5.235 161; and this is
also a continuation-in-part of application Ser. No. 07/213.
559, filed Jun. 30. 1988. now U.S. Pat. No. 4.988.623, and
a continuation-in-part of application Ser. No. 07625345,
filed Dec. 11. 1990, now U.S. Pat. No. 5.153,131,
ORIGIN OF THE INVENTION
The invention described herein was made in the perfor-
mance of work under a NASA contract and is subject to the
provisions of Section 305 of the National Aeronautics and
Space Act of 1958. Public Law 85-568 (72 Stat. 435; 42
U.S.C. 2457).
FIELD OF THE INVENTION
The invention relates to production of functional three
dimensional mammalian tissue from a culture of normal
cells in fluid media.
BACKGROUND OF THE INVENTION
The culturing of mammalian cells presents many chal-
lenges as compared to bacteria, yeast and molds. Bacterial-
type cells have tougher outer cell walls and can be manipu-
lated without injuring the cells during culture, whereas
mammalian cells are delicate and cannot withstand stress.
Bacterial-type cells are not organized into functional tissue
groups with cell differentiation or organization as seen in
higher life forms such as mammals.
Mammalian tissue can be grouped into three general
categories of (1) organ tissue (2) structural tissue and (3)
blood producing tissue. Mammalian tissue is composed of
aggregates of cells that share a functional interrelationship in
order to have tissue growth. Mammalian tissue is composed
of different types of cells characterized by different mor-
phology and imnwnochemical properties. Cellular differen-
tiation in mammals involves complex interactions in which
cell membrane junctions, extracellular matrices such as
basement membrane and ground substances. Soluble signals
produced and shared among the cells play an important role.
Study of normal mammalian tissue, however, has been
limited because of lack of adequate in vitro culture systems
that product tissue of sufficient size and functionality. In
contrast, tumor cells are by their nature easier to grow in
vitro, possess abnormal growth characteristics and do not
behave like normal cells in their interaction with neighbor-
ing cells. Sutherland. "Cell and Environment Interactions in
Tumor Microregions: The Multicell Spheroid Model",
Science, Vol. 240. pp. 177-240. 8 Apr. 1988. Different
culture methods for normal and abnormal mammalian cells
have been used. Elaborate culture systems for normal mam-
malian cells have been developed in an attempt to grow
normal tissue.
A variety of different cells and tissues, such as bone
marrow, skin. liver, pancreas, mucosal epithelium, adeno-
carcinoma and melanoma, have been grown in culture
systems to provide three dimensional growth in the presence
5 of a preestablished stromal support matrix. U.S. Pat. No.
4,963,489, Three-Dimensional Cell and Tissue Culture
System. Naughton, et al.. Oct. 16, 1990: U.S. Pat. No.
5,032,508. Three-Dimensional Cell and Tissue Culture
System. Naughton, et al.. Jul. 16. 1991. A biocompatible.
10 non-living material formed into a three dimensional struc-
ture is inoculated with stromal cells. In some cases, the three
dimensional structure is a mesh pre-coated with collagen.
Stromal cells and the associated connective tissue proteins
naturally secreted by the stromal cells attach to and envelop
15 the three dimensional structure. The interstitial spaces of the
structure become bridged by the stromal cells, which are
grown to at least subconfluence prior to inoculating the three
dimensional stromal matrix with tissue-specific cells.
Normal manunalian tissue has been grown for limited
20 periods of time as two-dimensional monolayers on gelled
substrate or other surface for anchoring the cells. Adult
colonic epithelial cells have been found to be more difficult
to culture than fetal colonic epithelial cells. Buset et al.
"Defining Conditions to Promote the Attachment of Adult
25 Human Colonic Epithelial Cells". In Intro Cell. & Dev. Biol..
Vol. 23. No. 6 pp. 403-412 (June 1987). To mimic a more
normal environment using monolayer culture, cocultures
were prepared using two cell types, often with a "feeder
layer" of fibroblasts or other cells to supply the primary cells
30 with nutrients and other factors difficult to incorporate into
a substrate and to provide the cellular interaction believed to
be necessary for the production of differentiated tissue. Reid
et al.. "Culturing Hepatocytes and Other Differentiated
Cells". Hepatology. Vol. 4. No. 3. pp. 548-559 (1984):
35 Haake et al. "Retention of Differentiated Characteristics in
Human Fetal Keratinocytes In Vitro", In Vitro Cell. & Dev.
Biol., Vol. 25 No. 25 pp. 592-600 (July 1989). Also.
monolayers "conditioned" with fibroblast cells have been
used to impart into the substrate the soluble growth factors
4o for epithelial cells. Kabalin et al. "Clonal Growth of Human
Prostatic Epithelial Cells Is Stimulated by Fibroblasts", The
Prostate, Vol. 14, pp. 251-263 (1989). Monolayers do not
produce a three dimensional tissue, but rather a two-
dimensional spread of cells. Often the cells developed by
45 monolayer culture and coculture become undifferentiated
and lack normal function.
Three dimensional in vitro models of differentiated tissue
have been produced, however, the cells often do not dem-
onstrate normal cellular activity. Embryonic avian skeletal
50 muscle cells have been grown in vitro on expandable
membranes which are gradually and substantially, continu-
ously stretched to simulate the mechanical stimulation of
cells experienced in vivo. U.S. Pat. No. 4.940.853, Method
for Growing Tissue Specimens in Vitro, Vadenburgh, Jul. 10.
55 1990. The expandable support membrane supports develop-
ment of three dimensional structures which more closely
resemble tissue grown in vivo, however, normal indepen-
dent cellular activity was not identified. Additionally, three
dimensional human mammary epithelial cells have been
60 grown in collagen. U.S. Pat. No. 5.026.637. Soule. et al..
Jun. 25. 1991. However, the cells, under the culture
conditions, did not undergo terminal differentiation and cell
senescence, but rather were "immortal' in that they retained
the capacity to divide forever. Thus, normal cellular activity
65 and naturalization was not observed.
The study of the organ systems exemplifies the complex
interrelationship of neighboring cells in mammalian tissue
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necessary for normal three dimensional tissue growth. Mam-
malian organ systems have been studied to determine the
relationship of the cell types that make up the organ as well
as their effects on each other. Studies on normal tissue
differentiation have indicated an important interaction
between epithelial cells and mesenchymal cells and the
production and differentiation of the cells from fibroblasts.
Kaye et al., `The Colonic Pericryptal Fibroblast Sheath:
Replication. Migration. and Cytodifferentiation of a Mesen-
chymal Cell System in Adult Tissue" Gastroenterology, Vol.
60. No. 4, pp. 515-536 (1971). Furthermore, small intestine
tissue is exemplary of organ tissue types with epithelial cells
with functional brush borders and organized columnar cells
associated with mesenchymal cells. Other organs have simi-
lar organization. Small intestine tissue has physical support
in vivo so that the tissue forms crypts which increase the
surface area of the organ. In addition to the crypt formation
in vivo, there are also immunocytochemical markers for
particular cell types with normal functionality as well as cell
types that are in developmental phases to produce functional
organ tissue.
Immunochemical properties further characterize normal
cells types and tissue. Keratin, vimentin and Factor VIII
antibodies detect epithelial, fibroblastic and endothelial cells
respectively. Villin is a cytoskeletal protein only found in
epithelial cells from the small intestine and colon. The
angioblast marker is present in certain precursor endothelial
cells, particularly dividing cells. Sucrase is an enzyme found
in the epithelial cell brush border of the small intestine.
Basement membrane and extracellular matrix components
such as laminin, fibronectin. Collagen IV, and proteoglycan
are associated with ordering of tissue and cellular polarity.
Basement membrane and extracellular matrix development
has been related to epithelial-mesenchymal development
and differentiation. All these components are necessary for
normal tissue growth.
Culture of normal or neoplastic small intestine epithelium
as large-scale three dimensional configurations has not been
shown with routinely used in vitro culture technology.
Chantret et al.. "Epithelial Polarity, Villin Expression and
Eterocytic Differentiation of Cultured Human Colon Carci-
noma Cells: A survey of Twenty Cell Lines" Cancer Res..
Vol. 48, pp. 1936-1942 (Apr. 1. 1988). Factors that control
proliferation and differentiation in the gastrointestinal tract
remain largely unknown. Corps et al.. "Stimulation of Intes-
tinal Epithelial Cell Proliferation in Culture by Growth
Factors in Human and Ruminant Mammary Secretions" J.
Endocr., Vol. 113, pp. 285-290 (3 Nov. 1986); O'Loughlin
et al., "Effect of Epidermal Growth Factor on Ontogeny of
the Gastrointestinal Tract" Am. J. Physiol.. Vol. 249. pp.
G674-;678 (8 Jul. 1985): Blay et al.. "Contradistinctive
Growth Responses of Cultured Rat Intestinal Epithelial
Cells to Epidermal Growth Factor Depending on Cell Popu-
lation Density" J. of Cell. Physiol.. Vol. 129, pp.343-346 (15
Jul. 1986).
Cartilage tissue is exemplary of normals structural tissue.
Attempts have been made to encourage cartilage formation
in vitro by culturing chondrocytes. Typical culture durations
achieved in the more successful instances range from 10
days to 30 days, the 30-day point being a transition towards
static culture or cellular degeneration and death. The success
achieved to date has had Limited 3-dimensionality. Typical
cell culture methodologies include isolating chondrocytes
from various articular surfaces and plating the isolated
chondrocytes as a monolayer in a T-flask. Various manipu-
lations were then utilized to encourage chondrocyte expan-
sion and differentiation, and the deposition of proteoglycan
into the interstitial matrices. These maneuvers include vari-
ous growth factor augmentations, an effort to emulate in situ
conditions. The extent to which the cells can be maintained
in situ is on the order of tens of years as seen in the normal
5 adult. Conversely, in standard cell culture the extent which
cells can be maintained in a growth phase or a normal static
maintenance phase is on the order of 22 days. It has been
demonstrated that multiple cell-surface receptors exist that
are important in cellular growth and differentiation, and
to extracellular matrix formation. Cell surface receptors are
labile to destructive cell surface sheer.
Cartilage cells were reportedly cultured for 13 months
using a solid substrate in conventional culture vessels. U.S.
Pat. No. 4.757,017 Cheung et al.. Jul. 12, 1988. The solid
15 substrate was a porous calcium compound. Multilayer cell
growth was observed and the cells maintained their pheno-
type.
Bone marrow has been grown using conventional mono-
layer cell culture technique. Human bone marrow cell cul-
zo ture technique. Human bone marrow cell production
declines over time in monolayer culture. Naughton et. al.
disclosed a bone marrow culture system in co-culture with
stromal cells or mixtures of cell types on a three dimensional
support. U.S. Pat. No. 4,963.489. The three dimensional
25 support was coated by cells such as fetal fibroblasts over a
collagen layer on a mesh support.
Mammalian tissue has been grown in bioreactors provid-
ing low shear from abnormal cell types such as tumor cells
30 or cocultures with normal and tumor cells. Goodwin et al..
"Morphological Differentiation of Colon Carcinoma Cell
Lines HT-29 and HT-29K in Rotating-Wall Vessels." In Vitro
Cell. Dev. Biol. Vol. 28A, pp. 47-60, January 1992. The
bioreactor designs are disclosed in U.S. Pat. Nos. 4,988,623:
35 5.026.650 and 5.153,131. Co-culture of tumor and normal
cells in solid-state culture has been reported as shown in
U.S. Pat. No. 4.352.887 to Reid et al. issued Oct. 5. 1982.
However, since tumor or abnormal cells grow under condi-
tions that normal cells cannot tolerate, the growth of non-
40 normal cells does not predict success for normal mammalian
culture under the same or similar culture conditions.
There are many potential uses of artificially produced
tissue for different mammalian systems. For example, small
intestine tissue can be used as a model for the molecular and
45 clinical treatment of diseases such as inflammatory bowel
disease (Crohn's, ulcerative colitus). malabsorptive syn-
dromes (short-gut syndrome), numerous infectious diseases
and tumors of the small bowel. The tissue can be a model for
the therapeutic trials prior to in vivo experimentation. How-
50 ever cultures longer than 7 weeks have been difficult to
achieve, since crypt cells are unable to survive standard
culture regimens, and two-dimensional organ cultures do not
support the de novo assembly of stroma and its contribution
to epithelial cell growth. Shamsuddin, "Colon Organ Culture
55 as a Model for Carcinogenesis". Colon Cancer Cells, Moyer
and Poste, Eds. Academic Press, Inc. 1990.
Also, a mammalian structural tissue such as a cartilage
model of high fidelity is important in clinical studies. There
are numerous maladies associated with cartilage, including
6o but not limited to knee-joint injuries, back injuries, articular-
surface injuries. inflammatory diseases such as arthritis and
temporal-mandibular joint disease. Beyond the diseases are
the natural processes of maturation through puberty and the
geriatric inability to repair and maintain articular surfaces. A
65 tissue model would be beneficial for the analyses and
development of therapeutic protocols. Moreover, these mod-
els become essential in tailoring pharmaceuticals, i.e.: non-
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steroidal anti -infl ammatories where the pharmaceutical may
actually become detrimental to the chondrocyte by way of
degradation into secondary metabolites.
The artificial production of functional blood tissue such as
normal bone marrow could be used in patients in need of
bone marrow replacement which have lost the ability to
produce the tissue. The tissue could be grown from a sample
and transplanted back to the patient. Also, bone marrow
material can be transplanted into a non-autologous recipient.
SUMMARY OF THE INVENTION
Aggregates of normal mammalian cells have been pro-
duced in vitro for each of the three major tissue groups. The
cell aggregates exhibited three dimensional tissue growth
and functional interrelationship by cell to cell contact.
Functional cells with normal morphology have been pro-
duced for organ, structural and blood producing tissues. Cell
function was in some cases confirmed immunohistochemi-
cally by antibodies specific to particular cellular components
characterizing cell types.
The aggregates were produced under "microgravity cul-
ture conditions" which can be microgravity or simulated
microgravity. Simulated microgravity was created in unit
gravity by controlling the horizontal rotation of a culture
vessel containing normal mammalian cells, culture matrix
and completely filled with culture media. In the preferred
process a horizontally rotating wall culture vessel produced
the simultaneous conditions of (1) collocation of cells and
culture matrix with similar or differing sedimentation prop-
erties in a similar spatial region. (2) freedom for three
dimensional spatial orientation of tissues formed by the
culturing of the cells and (3) low shear and essentially no
relative motion of the culture environment with respect to
the walls of the culture vessel. The culture conditions
included mass transfer under microgravity conditions with
exchange of nutrients for metabolic waste and appropriate
gas exchange in the culture system.
The process for producing the normal mammalian tissue
is particularly unique in that the resultant product is normal
tissue of a size of 2 millimeters and larger. The size of the
tissue cultured is significant because assembly of three
dimensional masses of this size is not possible without the
complex functional interrelationship of the normal mamma-
lian cells.
Functional three dimensional organ tissue masses have
been produced artificially from an inoculum of predomi-
nantly normal differentiated epithelial cells and predomi-
nantly normal differentiated mesenchymal cells. The epithe-
lial and mesenchymal cells were preferably disassociated
prior to introduction into the culture vessel. The epithelial
and mesenchymal cells were introduced in a vessel with a
culture matrix preferably of generally spherical microcarri-
ers. Tissue engineering was achieved by selected introduc-
tion of the mesenchymal cells and culture matrix for a
preselected culture period prior to transfer of epithelial cells
to the culture vessel.
A three dimensional normal organ tissue mass grew in
association with the culture matrix having functional epi-
thelial cells and functional mesenchymal cells. Also, the
tissue developed cells immunochemically characterized as
functional endothelial precursor cells in significantly greater
numbers than were present in the initial inoculum. The organ
tissue mass also developed cells immunochemically char-
acterized as functional angioblasts and cells that were immu-
nochemically characterized as functional epithelial cell
brush borders. Organized columnar cells were clearly vis-
ible. The developing organ tissue included cells immu-
nochemically characterized as basement membrane compo-
nents. As the tissue masses grew anchored to microcarriers
they were joined with cord-like structures of fibroblasts
5 covered by epithelial cells.
A preferred fluid media for mammalian organ tissue
culture is a MEM (minimum essential medium) base with a
tri-sugar supplement and fetal bovine serum. The preferred
tri-sugar supplement is selected from mixtures of fructose,
to galactose and glucose.
The organ tissue can be initiated by various normal
mammalian organ cells including skin, small intestine.
pancreas, liver, colon, and endocrine gland. Predominantly
normal terminally differentiated cells were able to revert to
15 a state that allowed interaction of a growing cellular mass
capable of normal organ tissue evolution without using
non-differentiated cells and without using cell types such as
tumor cells that have abnormal cell growth characteristics.
20 Artificially produced structural tissue has been produced
in microgravity culture conditions from normal structural
tissue. The three dimensional structural tissue mass devel-
oped with functional chondrocytes and stromal cells with
tissue calcification. The tissue exhibited matrix deposition
25 including cells immunochemically characterized as produc-ing Type IV. Type IX and Type X collagen. The structural
tissue is cultured in a vessel at microgravity conditions as
described herein with a culture matrix. A preferred culture
matrix was generally spherical microcatriers. An initial
30 inoculum used in the process to produce the structural tissue
mass was nonhuman embryonic cartilage cells disassociated
prior to transfer to the culture vessel.
Three dimensional mammalian blood tissue of normal
origin has been produced artificially. The bone marrow
35 tissue was prepared from normal bone marrow cells. The
inoculum from the bone marrow include pleuripotential
stem cells, fully matured white blood cells and red blood
cells. The bone marrow cells were transferred into a culture
vessel with fluid culture media and culture matrix. Micro-
40 gravity culture conditions as described herein were main-
tained while three dimensional tissue growth was achieved.
The culture matrix can be disc-shaped. The bone marrow
can be encased in stromal-like matrices and introduced into
the vessel. Also, culture matrix of Type I rat tail collagen and
45 biopolymers can be used.
Relatively large normal mammalian three dimensional
tissue masses were cultured using microgravity culture
conditions. The ability of the cells to grow into large
aggregates supports the functional relationship achieved by
50 cell to cell contact of normal cells. The process and normal
tissue of this invention can be used advantageously as an in
vitro produced mamma lian product.
BRIEF DESCRIP'T'ION OF THE DRAWINGS
55	 FIG. 1 is a view at 200x magnification of a three dimen-
sional artificial normal organ tissue mass.
FIG. 2 is a photograph of artificial normal organ tissue at
200x magnification.
FIG. 3 is a photograph of artificial normal organ tissue at
500x magnification.
FIG. 4 is a photograph of artificial normal organ tissue at
1500x magnification.
FIG. 5 is a photograph of artificial normal organ tissue at
65 50x magnification.
FIG. 6 is a photograph of artificial normal structured
tissue at 500x magnification.
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FIG. 7 is a photograph of artificial normal structural tissue
at 1500x magnification.
FIG. 8 is a photograph of artificial normal structural tissue
at 200x magnification.
FIG. 9 is a photograph of artificial normal structural tissue
at 1500x magnification.
FIG. 10 is a schematic drawing of the blood producing
tissue cells and microcarriers.
DETAILED DESCRIPTION  OF THE
INVENTION
Aggregates of cells from the three major tissue groups
were cultured in vitro. The artificially produced tissue
masses exhibited normal morphology and cell function.
Examples of organ tissue, structural tissue and blood tissue
are described below.
The artificially produced mammalian organ tissue was
generated from normal small intestine epithelial and mes-
enchymal cells. Human small intestine epithelial and mes-
enchymal cells were obtained from normal organs of
patients, predominantly organ transplant donors, with no
evidence of disease. The cells were then propagated in
culture. The cells were initiated and propagated in M3 media
supplemented with 2% fetal bovine serum (FBS). designated
M3:2, for epithelial cells or with 10% FBS. designated
M3:10. for mesenchymal cells. M3 medium is a complex
base medium supplemented with many growth factors and
nutrients including L-Broth (tryptone broth), bovine pitu-
itary extract, hydrocortizone, essential and non-essential
amino acids, pentagastrin, epidermal growth factor.
transferrin, selenium, and insulin. Moyer, "Methods for
Propagation and Characterization of Human GI and Other
Cells for Study of HIV," J. Tiss. Cult. Meth.. Vol. 13, pp.
107-116 (1991).
All cell cultures were grown in a Forma humidified CO,
incubator with 95% air. 5 %n CO.. and constant atmosphere
at a temperature of 37° C. Normal mesenchymal cells were
passaged as required by enzymatic dissociation with a
solution of 0.1% Trypsin. 0.1% EDTA, for 15 minutes at 37°
C. After incubation with the appropriate enzymes, the cells
were centrifuged at 800xG for 10 minutes in Corning
conical 15-m1 centrifuge tubes. The cells were then resus-
pended in fresh medium and diluted into Corning T-flasks
with 25 ml of fresh growth medium. Small intestine epithe-
lial cells were passaged by dilution at a 1:2 ratio into fresh
M3:2 medium in T-flasks. Cultures of epithelial cells were
derived from the ileum and jejunum of three male donors
(22-35 years of age). Mesenchymal cells were obtained
from the submucosa of five donors (4 males, 17-27 years
old, and a 2-month-old female).
Normal mesenchymal cells were removed from T-75
flasks by enzymatic digestion, washed once with calcium-
and magnesium-free PBS (CMF-PBS), and assayed for
viability byTrypan Blue dye exclusion (GIBCO). Cells were
held on ice in fresh growth medium until inoculation. In the
preferred process the primary inoculum introduced into the
culture vessel was 2x10 5 mesenchymal cells/nil in a 125-m1
volume with 5 mg/ml Cytodex-3 microcarrier beads
(Pharmacia, Piscataway. N.J.). Cytodex-3 microcarriers
were Type 1, collage-coated dextran beads, 175 microns in
diameter. After the primary inoculum was prepared for
seeding, it was transferred to a culture vessel filled with
culture media and cultured at microgravity conditions.
In a preferred method the microgravity conditions were
simulated in unit gravity by a horizontal rotating wall vessel
(RWV). A preferred RWV bioreactor is described in U.S.
Pat. No. 5,026.650 to Schwarz et al. issued Jun. 25. 1991 and
is incorporated by reference herein. The rotation of the
culture vessel (bioreactor) was controlled to produce the
simultaneous conditions of (1) collocation of cells and
5 culture matrix with similar or differing sedimentation prop-
erties in a similar spatial region. (2) freedom for three
dimensional spatial orientation of tissues formed by the
culturing of the cells and (3) low shear and essentially no
relative motion of the culture environment with respect to
10 
the walls of the culture vessel. The trajectory of the cell
aggregates was determined. The speed of the rotation of the
culture vessel was increased if the cell aggregates fell
excessively inward and downward on the downward side of
the rotational cycle and excessively outward and insuffi-
ciently upward on the upgoing side of the rotational cycle to
15 prevent wall impact. The rotation of the culture vessel was
decreased in response to excessive accumulation of tissue
aggregation near the outer wall of the culture vessel so as not
to restrict three dimensional growth. As the tissue aggregates
grow the rotation was adjusted to obtain minimal collision
20 frequency and intensity.
The culture media used in the RWV can be varied. A 1:1
mixture of M3:2 medium and standard minimal essential
medium-alpha (MEM-alpha) .(GIBCO) supplemented with
10% FBS was used. A preferred media designated GTSF-2
25 was found to meet the growth requirements of the system
without the need for unique growth factors and other com-
plex components found in other media including M3:2. The
GTSF-2 media is a trisugar-based medium with glucose.
galactose and fructose supplemented with 6 %n FBS. A pre-
30 ferred formulation for GTSF-2 media is listed in Table 1
below. The pH was adjusted to 7.4 with IN NaOH.
TABLE 1
35	
Tri-Sugar Based Medium
GTSF-2
Source/Order or
Component	 Concentration	 Designation
MEM-alpha supplemen- 400 nil (40%) GIBCO/430-1900EB
40 ted with 2.25 gn/L
NaHCO3
L-15 600 ml (60%) GIBCO1430-1300EB
NaHCO3 1.35 gm/liter Sigma/S-5761
HEPES 3.0 gtn/liter Research Or-
ganics/6003H-2
45	 Folic acid 6.667 Ng/liter Sigma/F-8758
0.5% Nicotinic acid 0.667 ml/liter Sigma/N-4126
Bactopeptone 0.6 gm/Liter Difco/0118-01
I-mositol 0.024 gm/liter Sigma/1-5125
Fructose 0.13 gm/liter Sigma/F-3510
Galactose 0.25 gm/liter Signa/G-5388
D-Glucose 1.0 gm/liter Sigma/G-5250
50 300mM L-Glutamine 10 ml/liter Sigma/G-5763
Gentamycin 1 mllliter GIBCO/600-5750AD
Ftnngizone 2 hinter GIBCO/600-5295AE
Insulin-tiansferrin- 5 ml/liter Sigma/1-1884
sodium-solenite
Fetal bovine serum 60 ml (6%) Hyclone/A-1111-L
55
The primary inoculum of mesenchymal cells was allowed
to grow for a minimum of 2-3 days before the medium was
changed. Then 2x10 5 epithelial cells/ml were added pre-
60 pared as described above for the mesenchymal cells. The
organ tissue can be bioengineered to develop desired pat-
terns of cell layering by preselecting the introduction of the
epithelial cells into the culture vessel. Also, the cells can be
introduced essentially simultaneously into the vessel to
65 produce normal organ tissue.
Culture conditions included mass transfer with exchange
of nutrients for metabolic waste and appropriate gas
5.846.807
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exchange in the culture system. Fresh medium was replen-
ished by 65% of the total vessel volume each 20 to 24 hours.
As metabolic requirements increased, fresh medium was
supplemented with an additional 100 mg/dl of glucose.
Viable cocultures grown in the RWVs were harvested over
periods up to 45 days and prepared for various assays.
The artificial organ tissue mass was produced in the RWV
in both a 1:1 mixture of M3:2 and MEM alpha supplemented
with 10%n fetal bovine serum (Hyclone Laboratories, Logan,
Utah) and tri-sugar based media shown in Table 1 on a
preferred culture matrix of 5 mg/ml Cytodex-3 generally
spherical nucrocarriers (Pharmacia. LKB). The three dimen-
sional tissue cultures grown in the M3:2 and MEM media
attained cell densities of 2.3-3.2x10 5 cells/ml and although
the cultures did not reach plateau phase, suggesting the
potential for continued growth, the epithelial cell contingent
exhibited signs of considerable stress while the mesenchy-
mal cells proliferated well.
The preferred tri-sugar based media was found to meet the
growth requirements without the need for multiple growth
factors and supplements. The cultures in the tri-sugar based
media produced slightly higher average cell densities, 4.6 to
6.2x 106 cells/ml as compared to the M3:2 and MEM media
which exhibited cell densities of 2.5-3.2x10 6 cells/nil. The
three dimensional tissue mass grown in the tri-sugar based
media exhibited an epithelial cell component which
appeared to proliferate in a more normal and appropriate
fashion. The cultures were not grown to the plateau phase,
indicating further capability for continued growth. The arti-
ficial tissue did not reach maximum cell densities after
38-45 days of culture.
The tissue masses grew to relatively large sizes as com-
pared to other in vitro methods. After 300 hours of culture
the tissue/microcarrier mass was about 0.2-0.3 cm in size
with masses increasing to about 0.4-0.6 cm after approxi-
mately 500 hours of culture and over 0.6 cm after 800 hours
of culture.
The epithelial cells and mesenchymal cells used to seed
the cultures were immunophenotyped and compared to the
three dimensional tissue cultured in the RWV. Samples were
harvested at intervals during the culture process for immu-
nocytochemical analysis. The antibodies used to immu-
nochemically characterize the cell types are listed in Table
2 below.
TABLE 2
ANTIBODIES USED FOR 1304UNOCYTOCHEMICAL ANALYSIS
Source/Order No. or
Antibody Specificity Dilution Designation
Pancytokeratiu prediluted DAKO.IncJL1824
Vunentin prediluted DAKO.IncJL1843
Factor VIII prediluted DAKO, IncJL1809
Villin 1:20 Chemicon, Temacria,
CA/MA.B 1671
Sucrase 1:20 A. Elbein, UTHSCSAIYT
Angioblasts 1:20 Accurate Chem, Westbu-
ry CA/HE3-5/47
Lan u n 1:20 ICN, Costa Mesa, CA/69-
630
Fibronectin 1:20 US BIOCH. Cleveland.
OIV33752
Proteoglycan 1:20 Biological Products for
Science, Oxford, UK/MCA
326
Collagen Type IV 1:20 DAKO. Inc./M785
The keratin. vimentin, and Factor VIII antibodies detect
epithelial. fibroblastic, and endothelial cells, respectively.
10
Villin is a cytoskeletal protein only found in epithelial cells
from small intestine and colon. The angioblast marker is
present in subsets of precursor endothelial cells, particularly
dividing cells. Sucrase is an enzyme found in the epithelial
5 cell brush border of the small intestine. Basement membrane
and extracellular matrix components laminin, fibronectin,
Collagen IV, and proteoglycan were also assayed to deter-
mine their expression in the artificially produced three
dimensional tissues.
10 Cultured organ tissue grown on Cytodex-3 microcarriers
in the RWV were fixed in OmniFix, an alcohol-based
fixative not containing aldehydes or mercury (Xenetics
Biochemic. Tustin. Calif.). At all times, extreme care was
taken not to damage the delicate artificial tissue comprised
15 of cellular material and microcarrier beads. When an abun-
dance of beads was present, the supernatant fluid was
carefully decanted and a sample of beads was enclosed in a
biopsy bag, then placed in a cassette to prepare a paraffin
block. When bead clusters were scarce, a Shandon Cytob-
20 lock Kit (Shandon Inc.. Pittsburgh, Pa.) was used. Cassettes
were processed in a standard tissue processor. Five-micron
sections were cut from the paraffin-embedded tissues, depar-
affinized by standard procedures, then assayed by incubation
with the test antibodies (Table 2) followed by use of the
25 universal labeling streptavidin biotin (LSAB) kit (DAKO
Inc., Carpenteria, Calif., No. K680). which detects mouse
monoclonal and rabbit polyclonal antibodies. The immuno-
cytophenotyping was confirmed by one positive and two
negative controls. The positive control was normal tissue-
30 .sections or normal cells positive for the primary antibody
used. The negative controls were 1) PBS only, to test for
false binding by "link" antibody and streptavidin, and 2)
normal serum of the same species from which the primary
antibody was prepared.
35 Analysis by immunocytochemistry was used to confirm
the ability of the seed cells to produce a three dimensional
artificially produced tissue mass with functional epithelial
cells and functional mesenchymal cells as well as functional
precursor endothelial cells that were not present in the seed
40 culture. As the culture progressed and the tissue mass grew
it included functional angioblasts.
Immunophenotyping of the cell types used to seed the
coculture in the RWV confirmed the majority of epithelial
and mesenchymal cells seeded were keratin and vimentin
45 positive, respectively. In addition, the epithelial cells were at
various stages of differentiation. Only a small percentage
(Q%) of the cells was positive for Factor VDI, an endot-
helial cell differentiation marker. Table 3 is a summary of the
immunochemical staining reaction of the three dimensional
50 tissue of the present invention. The tissue was harvested at
various intervals up to 41 days as noted in Table 3.
An increased percentage >10% of cells present in the
masses consisted of endothelial cells which were Factor VIII
positive as confirmed by immunochemistry and growing as
55 patches on the beads. Furthermore, a small percentage.
1-2% of cells, showed de novo expression of the HE-3
angioblast antigen which was not present in the seed cultures
of mesenchymal cells confirming the presence of angioblasts
in the tissue by immunochemistry. Functional cell brush
60 borders were confirmed immunochemically by the presence
of Sucrase.
FIG. 1 is a photograph of the small intestine artificially
produced organ tissue at 200x magnification showing the
three dimensional cell aggregate generally indicated by the
65 arrows. FIG. 2 is a photograph of the small intestine organ
tissue. The triangular markers at 2 and 4 in the photograph
are for reference on the microcarriers. A mass of epithelial
5,846.807
11	 12
cells is shown at 6. Elongated mesenchymal cells are grow-
ing on the microcarriers as shown at 8 and 10. FIG. 3 is a
higher magnification (500x) of the epithelial mass shown at
6 in FIG. 2. FIG. 4 shows the organized columnar epithelial
cells of the small intestine organ tissue at arrows 12 and 14.
FIG. 5 shows the three dimensional organ tissue masses
joined by cord-like structures of fibroblasts (mesenchymal
cells) covered by epithelial cells.
TABLE 3
SUMMARY OF 1MMUNOCHEMICAL STAINING ON TISSUE
GROw'171 IN RWV*
Antibodies
Specificity or
Cell Stained 13
Days Grown in RWV
23	 25	 37 41
Keratin Epithelial, Cyto- +++ +r+ ++ ++ ++
skeletal
Ymtentin Fibroblasts, some ++t +++ ++ ++ ++
endothelial
Factor VIII Endothelial ++ +++ ++ ++ ++
Villin Epithelial, small + + + + +
intestine
HE3 Angioblasts – – – ++ ++
Sucrase Small intestine. +++ + ++ ++ ++
cell brush border
Lammin Basement membrane + + – + ++
Fibronectin Basement membrane + + ++ ++ —
Proteoglycan Extracellular +++F ++1 ++++ +1 ++++
matrix
Collagen Extracellular ++ + + ++ ND
Type IV matrix
*Slides were observed and scored on a relative scale as - (negative) to +...
(maximum staining; very dark positive for >90% of the cells); + indicates
weaker staining for –25-50% of the cells; ++ indicates moderate staining for
greater than 50-75% of the cells.
Samples from the RWV cultures were taken for scanning
electron microscopy at the same times as those taken for
immunocytochemistry. After removal from the reactor
vessels, samples were washed once with CMF-PBS. The
samples were suspended in a buffer containing 3% glutaral-
dehyde and 2% paraformaldehyde in 0.1M cacodylate buffer
at pH 7.4, then rinsed for 5 minutes with cacodylate buffer
three times and postfixed with 1% osmium tetroxide
(Electron Microscopy Sciences, Fort Washington, Pa.) in
cacodylate buffer for 1 hour. Samples were then rinsed for
5 minutes with distilled water three times and then treated
for 10 minutes with Millipore (Millipore Corp., Bedford.
Mass.) (0.2N) filtered, saturated solution of thiocarbohy-
drazide (Electron Microscopy Sciences), then washed for 5
minutes with distilled water five times and fixed with 1%
buffered osmium tetroxide for 10 minutes. This last step was
necessary to prevent the microcarriers from collapsing.
Samples were then rinsed with distilled water three times
and dehydrated with increasing concentrations of EtOH
followed by three changes in absolute methanol. After
transfer to 1, 1, 1, 3, 3, 3-hexamethyldisilazane (HMDS)
(Electron Microscopy Sciences) samples were allowed to
soak for 10 minutes, drained, and air dried overnight. Dried
samples were sprinkled with a thin layer of silver paint on
a specimen stub, dried, coated by vacuum evaporation with
platinum-palladium alloy, and then examined in the JEOL
T330 Scanning electron microscope at an accelerating volt-
age of 5 to 10 kV.
Micrographs taken of 6- to 7-day cocultures showed
partial coverage of the microcarriers by normal small intes-
tine mesenchymal cells. Additionally, large developing
masses of small intestine epithelium were evident, growing
on the microcarrier beadpacks. Samples harvested at
approximately 12 days of culture contained small microcar-
rier packs which were totally engulfed in proliferating small
intestine epithelium. Micrographs of samples at 13 days
displayed large tissue-like masses that were entirely covered
with small intestine epithelium grown on a base layer of
5 mesenchymal cells. Areas of organized columnar epithelium
were prominent. As the cultures matured into mid- and
late-stage cultures, extremely complex tissue-like masses
comprised of mesenchymal and epithelial cells were seen
from approximately 16 days of culture until termination at
10 41 days. These tissues were assembled from smaller masses
which were joined by cord-like structures of fibroblasts and
covered by epithelial cells several layers deep. In addition.
available microcarriers were drawn to the surface of these
large masses which were approximately 0.3 to 0.5 em in
diameter. Finally, columnar epithelium was observed to be
15 growing even in the recessed areas of the microcarrier bead
packs.
The artificially produced mammalian structural tissue was
generated from normal mouse embryonic femurs. The fetal
cells are a mixture of chondrocytes and stromal cells. The
20 cells were placed in a standard media commonly designated
as CMRL 1066 (Gibco Labs) containing 10% Fetal Bovine
Serum. The cells were disassociated by standard enzymatic
digestion. The single cells produced by enzymatic digestion
were washed several times in PBS and transferred into a
25 culture vessel with fluid culture media. The preferred culture
vessel is described in U.S. Pat. No. 5,026,650 and referenced
above. The vessel was steam sterilized by autoclaving at
standard temperature and pressure prior to transfer of the
cells.
30 A preferred culture matrix of generally spherical micro-
carrier Cytodex-3 beads were transferred into the culture
vessel. The approximate total cell inoculum was 132,000,
000 at a ratio of 30 cells per Cytodex-3 microcarrier bead.
The bead concentration of the vessel was 10 mg/ml (4000
35 beads/mg). The culture media in the vessel was CMRL 1066
with ascorbic acid 10 mg/ml added.
Microgravity conditions were simulated ifi culture vessel
as described and referenced herein. The vessel provided the
quiescent well-perfused environment for maintenance of
40 cell surface receptors and undisturbed cell-to-cell
co-location. Co-location is important for autocrine-paracrine
factor formation and exchange between cellular types, and
nurturing of differentiation with consequential matrix depo-
sition. The cells were cultured for up to 65 days. The tissue
45 masses grew to at least 0.4 cm in length after 1000 hours of
culture. The development of normal cartilage tissue was
evidenced by normal morphology of the chondrocyte and
stromal cell formation and cartilagineous tissue substruc-
tures. Also, tissue with calcification was produced. Also,
50 proteoglycan deposition was identified. The normal pattern
of Type H collagen deposition followed by down regulation
of Type H collagen deposition and enhanced formation of
Type IX and Type X collagen was observed.
Photographs taken during the culture period of the struc-
55 tural cells show the growth and normal development of the
tissue. FIG. 6 is a micrograph taken at 500x magnification
at 300 to 600 hours of culture of normal fetal mouse
chondrocytes. The cells grew around the generally spherical
microcarriers. FIG. 7 is a higher magnification showing
60 preliminary calcification at the arrow 20. FIGS. 8 and 9 were
taken after 900 to 1100 hours of culture with differentiated
fibroblastic chondrocytes shown in FIG. 9 at 22. Also,
stromal cells are show in FIG. 9 at 24.
The artificially produced blood tissue can be made from
65 human bone marrow samples or other sources of mamma-
lian origin. Human bone marrow samples are obtained by
standard clinical techniques under aseptic conditions. In
5,846.807
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general, a bone marrow tool is used to puncture the bone and
obtain a bone marrow sample that is fully inclusive of
normal constituents. The normal constituents will include,
but are not limited to: pleuripotential stem cells, fully
maturated white blood cells and red blood cells, stromal
components, and cells in intermediate stages of maturation.
Laboratory animals such as mice can be used as a source
of bone marrow for selected studies. After sacrificing mice,
the femur and tibia are removed and placed in 1xCalcium-
and Magnesium-free PBS with 200 Ng/ml pen-strep. Muscle
is removed and endcaps of the bones are cut. With a syringe
and 26G needle. the bone is flushed with cold complete
growth medium known to those skilled in the art such as
CMRL 1066. Cells are then poured through collector screens
to remove large pieces of tissue and suspended cells are
placed in 50-cc sterile tubes on cold complete growth
medium. Cells are washed and centrifuged three times to
insure no contamination. Cells are not treated with any
reagent to remove red blood cells.
The preferred culture vessel is described in U.S. Pat. No.
5.026.650 previously cited and incorporated by reference
herein. A fluid culture media is introduced into the sterilized
vessel. A preferred fluid culture media is a standard tissue
culture media commonly designated as RPM1-1640
(available from Gibco and other sources).
The sterile bone marrow cells are then transferred to fluid
culture medium and suspended. Suspended cells are
transferred, at approximate densities of 1x10 6 cells/ml, to
the culture vessel. Various cell matrices can be used. The
collected bone marrow cells can be encased in stromal-like
matrices. The matrices can be disc-shaped. Other matrices
are generally known can be used including, but are not
limited to, collagen matrices of Type I rat tail collagen or
other biopolymeric matrices. The biopolybers used can be
biodegradable such as suture materials. Cross-linked poly-
mers such as collagen, fibronectin and mixtures thereof may
be used. These matrices may have spherical diameters
ranging from 1 nullimeter to 10 millimeters and include the
necessary cellular constituents to facilitate primary bone
marrow culture. Cytodex-3 microcarriers can be introduced
into the vessel at a density of 5 mg/ml. Bone marrow cells
contained in the matrix or supported in suspension are
cultured at microgravity conditions and mass transfer as
described herein and the incorporated references.
Early in the initiation it is preferable that the cells are
allowed to grow and metabolize without sampling interrup-
tion. The first sampling may begin one to seven days after
inoculation. Consequently, cellular aggregates are not dis-
turbed and bone marrow growth factors are not diluted by
media repletion. After the lag phase, media repletion is
based upon requirements as previously described. Cellular
phenotyping is carried out by flow cytometry and light
microscopy.
FIG. 10 is a schematic drawing of the bone marrow cell
production. The disc-shaped culture matrices are shown at
30, 32 and 34. The bone marrow cells are shown as circular
14
figures at 36. 38 and 40. The arrows with the GF generally
indicate the excretion of growth factors from the normal
bone marrow cells that enhance tissue growth in the culture
system.
5 In the case of preparing bone marrow for recipients,
volumes are expanded as cellular densities or metabolic
requirements dictate. The limited parameters may depend
upon the rotating vessel's ability to suspend large
aggregates, in which case if unable to suspend large
to aggregates, smaller aggregates would be distributed through
several vessels. If the metabolic requirements were such that
mass transfer of oxygen and removal of carbon dioxide were
not sufficient to maintain cellular growth and expansion.
then cells would be aliquoted into additional vessels.
15 The examples included are not intended to limit the scope
of the present invention. Normal mammalian cells have been
cultured to produce aggregates of cells of three dimensional
tissue masses. Other substitutions, modifications and varia-
tions are apparent to those skilled in the art without depart-
20 ing from the disclosure and scope of the invention.
What we claim is:
1. A culture medium for non-neoplastic mammalian organ
tissue culture comprising:
25 
(a) minimal essential medium-alpha (MEM-ALPHATM);
(b) Leibovitz L-15 TM medium;
(c) tri-sugar supplement: and
(d) serum.
2. The culture medium of claim 1 wherein the tri-sugar
30 supplement is selected from mixtures of the group consisting
of fructose, galactose, and glucose.
3. The culture medium of claim 2 wherein said concen-
tration of fructose ranges from about 65 mg/liter to about
500 mg/liter.
35 4. The culture medium of claim 2 wherein said concen-
tration of galactose ranges from about 125 mg/liter to about
900 mg/liter.
5. The culture medium of claim 2 wherein said concen-
tration of glucose ranges from about 500 mg/liter to about
4o 4500 mg/liter.
6. The culture medium of claim 1 wherein the medium
further comprises sodium bicarbonate (NaHCO3).
7. The culture medium of claim 1 wherein the MEM-
ALPHATM base medium and LEIBOVITZ L- 15 TH medium
45 are in a 4:6 ratio.
8. The culture medium of claim 1 wherein said serum is
selected from the group consisting of bovine serum and calf
serum.
9. The culture medium of claim 1 wherein said serum
50 concentration ranges from about 3% to about 25%.
10. The culture medium claim 1 further comprising
gentamycin, fungizone, NaHCO 3 , HEPES, folic acid, nico-
tinic acid, bactopeptone, i-inositol. L-glutamine, and
insulin-transferrin-sodium selenite solution.
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